Higher PALI1 expression (using C10orf12 as a surrogate in database searches) correlates with improved overall survival (OS) in lung adenocarcinoma, smoke-related lung cancer, breast cancer without lymph node metastasis, gastric cancer, myeloma, and suboptimal ovarian cancer (Fig. 6A). Here, LCOR is linked to breast carcinoma.